Sun.Apr 23, 2023

article thumbnail

Dying patients protest looming telehealth crackdown

STAT News

At age 93, struggling with the effects of a stroke, heart failure and recurrent cancer, Teri Sheridan was ready to end her life using New Jersey’s law that allows medically assisted suicide — but she was bedbound, too sick to travel. So last Nov. 17, surrounded by three of her children, Sheridan drank a lethal dose of drugs prescribed by a doctor she had never met in person, only online.

Doctors 119
article thumbnail

Self-fitting, over-the-counter hearing aids beneficial

Medical Xpress

Self-fitting, over-the-counter (OTC) hearing aids produce self-reported and clinical outcomes similar to those of audiologist-fitted hearing aids for adults with mild-to-moderate hearing loss, according to a study published online April 13 in JAMA Otolaryngology-Head & Neck Surgery.

99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CBER to Launch Operation Warp Speed for Rare Diseases by Year’s End

BioSpace

CBER to Launch Operation Warp Speed for Rare Diseases by Year’s End 4/24/2023

134
134
article thumbnail

Stricter alcohol policies are associated with reduced drinking, multi-country analysis finds

Medical Xpress

People who live in countries with more stringent alcohol policies drank less than people in countries with less strict policies, according to a large multi-country analysis published in Alcohol: Clinical and Experimental Research. The more stringent policies were associated with reduced drinking overall and showed more significant associations in drinkers aged 18 to 24 and those with 13 or fewer years of education.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Ionis and AstraZeneca Seek to Challenge Alnylam with New ATTR Data

BioSpace

Ionis and AstraZeneca Seek to Challenge Alnylam with New ATTR Data 4/24/2023

101
101
article thumbnail

Inflammation 'brake' gene may help reveal outcomes of kidney disease

Medical Xpress

A discovery about gene variants of an inflammation 'brake' brings scientists a step closer to personalised treatment for patients at risk of kidney disease and kidney failure.

Gene 82

More Trending

article thumbnail

Postmarket Surveillance Studies with David Rutledge

Clinical Trial Podcast

In this episode, we’re going to talk about Postmarket Surveillance Studies. In light of the EU Medical Device Regulation (MDR), medical device manufacturers are required to implement a Postmarket Surveillance (PMS) plan, which in turn may require them to conduct Postmarket Surveillance Studies. To learn about Postmarket Surveillance Studies regulatory requirements, process for collecting clinical data for such studies, key elements of PMS plan, and more, I invited Dr.

article thumbnail

The Importance of Integration Between eTMF, EDC, and CTMS Systems

Cloudbyz

The clinical trial landscape is continuously evolving, with technology playing a crucial role in streamlining processes, managing data, and improving efficiency. Three essential systems that have become integral to clinical trial management are Electronic Trial Master Files (eTMF), Electronic Data Capture (EDC), and Clinical Trial Management Systems (CTMS).

article thumbnail

Supreme Court Maintains Mifepristone Access

BioSpace

Supreme Court Maintains Mifepristone Access 4/24/2023

88
article thumbnail

Unlocking the Potential of Electronic Trip Reports in CTMS Platforms

Cloudbyz

In recent years, Clinical Trial Management Systems (CTMS) have revolutionized the way clinical trials are conducted, offering numerous advantages to research organizations, pharmaceutical companies, and Clinical Research Organizations (CROs). One of the most significant features of CTMS platforms is the inclusion of electronic trip reports (eTrip Reports) capabilities.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

FDA Action Alert: Biogen/Ionis, Seres, Otsuka/Lundbeck and More

BioSpace

FDA Action Alert: Biogen/Ionis, Seres, Otsuka/Lundbeck and More 4/24/2023

74
article thumbnail

Medicare SNF Use and Spending Before and After Introduction of the Public Health Emergency Waiver

JAMA Internal Medicine

This cohort study examines whether skilled nursing facility (SNF) episode volume and Medicare spending on SNF care changed after introduction of the public health emergency waiver during the COVID-19 pandemic among long-term care residents and other Medicare beneficiaries.

Nurses 40
article thumbnail

FDA Delays Verdict for Daiichi Sankyo’s Quizartinib

BioSpace

FDA Delays Verdict for Daiichi Sankyo’s Quizartinib 4/24/2023

65
article thumbnail

A Brief History of the 3-Day Hospital Stay Rule

JAMA Internal Medicine

Ulyte and colleagues describe Medicare costs associated with the COVID-19–related public health emergency policies, specifically that waiving the requirement that use of the skilled nursing facility (SNF) benefit generally requires a 3-day prior hospital stay. They found substantial increases in use of the SNF benefit that were primarily associated with long-stay residents and largely during the early and worst of the pandemic.

Nurses 40
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Which pharmaceutical companies have the most drug patents in Ukraine?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Ukraine? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 96
article thumbnail

FDA’s Draft Guidance on Externally Controlled Trials Answers Some Questions, Leaves Others Unanswered

FDA Law Blog

By Mark A. Tobolowsky & David B. Clissold — The Draft Guidance In February 2023, CDER, CBER, and the Oncology Center of Excellence published a draft guidance titled “ Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products ” (the “Draft Guidance”) to provide recommendations to those considering the use of externally controlled clinical trials to provide evidence of safety and effectiveness of a drug product.

Trials 49